Doxycycline in the treatment of bleeding with DMPA: a double-blinded randomized controlled trial
Authors:
- Hany Abdel-AleemHAHany Abdel-Aleem
- Omar M. ShaabanOSOmar M. Shaaban
- Mahmoud A. Abdel-AleemMAMahmoud A. Abdel-Aleem
- Gihan N. FetihGFGihan N. Fetih
- 1 September 2012
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 86 (3) , 224-230
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implantContraception, 2009
- Progestogen only contraception and endometrial break through bleedingAngiogenesis, 2005
- Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleedingFertility and Sterility, 2003
- A functional model for progestogen-induced breakthrough bleedingHuman Reproduction, 2000
- The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestinonly contraceptivesHuman Reproduction, 2000
- Depot Medroxyprogesterone Acetate Use in Inner-city, Minority AdolescentsArchives of Pediatrics & Adolescent Medicine, 1999
- Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzymeArthritis & Rheumatism, 1999
- Depot medroxyprogesterone acetateContraception, 1997
- A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraceptionHuman Reproduction, 1996
- Angiogenesis in reproductive tissuesJournal of Endocrinology, 1986